RET-Positive Metastatic NSCLC


 

WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Combination With Osimertinib in EGFRm and MET Overexpressed NSCLC

156 views
August 18, 2022
0 Comments
Login to view comments. Click here to Login
RET-Positive Metastatic NSCLC